Top compounds associated with response to KCNRG


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA pac-1 CTRPv2 pan-cancer AAC 0.21 5e-08
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA Topotecan CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA CD-437 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA SN-38 CTRPv2 pan-cancer AAC 0.19 2e-06
Download CSV